BMB Reports

Korean Society for Biochemistry and Molecular Biology (생화학분자생물학회)
권호 표지
DOI QR코드

DOI QR Code

The Effect of Dimethyl Dimethoxy Biphenyl Dicarboxylate (DDB) against Tamoxifen-induced Liver Injury in Rats: DDB Use Is Curative or Protective

  • El-Beshbishy, Hesham A. (Biochemistry Department, Faculty of Pharmacy (Boys), Al-Azhar University)
  • Published : 2005.05.31
Download PDF
⟨ Previous Next ⟩

Abstract

Tamoxifen citrate is an anti-estrogenic drug used for the treatment of breast cancer. It showed a degree of hepatic carcinogenesis, when it used for long term as it can decrease the hexose monophosphate shunt and thereby increasing the incidence of oxidative stress in liver rat cells leading to liver injury. In this study, a model of liver injury in female rats was done by intraperitoneal injection of tamoxifen in a dose of 45 mg/kg body weight for 7 successive days. This model produced a state of oxidative stress accompanied with liver injury as noticed by significant declines in the antioxidant enzymes (glutathione-S-transferase, glutathione peroxidase and catalase) and reduced glutathione concomitant with significant elevations in TBARS (thiobarbituric acid reactive substance) and liver transaminases; sGPT (serum glutamate pyruvate transaminase) and sGOT (serum glutamate oxaloacetate transaminase) levels. The oral administration of dimethyl dimethoxy biphenyl dicarboxylate (DDB) in a dose of 200 mg/kg body weight daily for 10 successive days, resulted in alleviation of the oxidative stress status of tamoxifen-intoxicated liver injury in rats as observed by significant increments in the antioxidant enzymes (glutathione-S-transferase, glutathione peroxidase and catalase) and reduced glutathione concomitant with significant decrements in TBARS and liver transaminases; sGPT and sGOT levels. The administration of DDB before tamoxifen intoxication (as protection) is more little effective than its curative effect against tamoxifen-induced liver injury. The data obtained from this study speculated that DDB can mediate its biochemical effects through the enhancement of the antioxidant enzyme activities and reduced glutathione level as well as decreasing lipid peroxides.

Keywords

References

  1. Akcay, T., Dinner, Y., Kayali, R., Colgar, U., Oral, E. and Cakatay, U. (2000) Effects of hormone replacement therapy on lipid peroxides and oxidation system in postmenopausal womwn. J. Toxicol. Environ. Health 59, 1-5 https://doi.org/10.1080/009841000157023
  2. Ali, S. and Coombes, R. C. (2002) Endocrine responsive breast cancer and strategies for combating resistance. Nat. Rev. Cancer 2, 101-112 https://doi.org/10.1038/nrc721
  3. Atalay, G., Dirix, L., Biganzoli, L., Beex, L., Nooij, M., Cameron, D. and Lohrisch, C. (2004) The effect of exemestane on serum lipids profile in postmenopausal women with metastatic breast cancer. Ann. Oncol. 15, 211-217 https://doi.org/10.1093/annonc/mdh064
  4. Athoupa, M., Hirsimaki, P., Parssinen, R. and Mantyla, E. (1994) Alterations of drug metabolizing and antioxidant enzyme activities during tamoxifen-induced hepatocarcinogenesis in rats. Carcinogenesis 15, 863-868 https://doi.org/10.1093/carcin/15.5.863
  5. Baek, M. S., Kim, J. Y., Myung, S. W., Yim, Y. H., Jeong, J. H. and Kim, D. H. (2001) Metabolism of DDB by human liver microsomal cytochrome P450: probable involvement of CYP3A and CYP1A2. Drug Metab. Dispos. 29, 381-388
  6. Bensky, D. and Gamble A. (1993) Traditional indications of DDB; in Chinese Herbal Medicine, Medica, M. (eds), pp. 110-112, Eastland Press, Seattle, USA
  7. Caballero, F., Gerez, E., Oliveri, L., Falcolff, N., Battle, A. and Vazquez, E. (2001) On the promoting action of tamoxifen in a model of hepatocarcinogenesis induced by p-dimethylaminobenzene in CF1 mice. Int. J. Biochem. Cell. Biol. 33, 681-690 https://doi.org/10.1016/S1357-2725(01)00056-5
  8. Clairborne, A. (1985) Catalase activity; in Handbook of Methods for Oxygen Radical Research, Greenwald, R. A. (ed.), p. 383, CRC press, Boca Raton, USA
  9. Dehal, S. S. and Kupfer, D. (1997) CYP2D6 catalyzes tamoxifen 4-hydroxylation in human liver, Cancer Res. 57, 3402-3406
  10. Dehal, S. S. and Kupfer, D. (1999) Cytochrome P450 3A and 2D6 catalyze ortho hydroxylation of 4-hydroxytamoxifen and 3-hydroxytamoxifen (droloxifene) yielding tamoxifen catechol: involvement of catechols in covalent binding to hepatic proteins. Drug Metab. Dispos. 27, 681-688
  11. Desai, P., Nallani, S., Sane, R., Moore, L., Goodwin, B., Buckley, D. and Buckley, A. (2002) Induction of Cytochrome P450 3A4 in Primary Human Hepatocytes and Activation of the Human Pregnane X Receptor by Tamoxifen and 4-Hydroxytamoxifen. Drug Metab. Dispos. 30, 608-612 https://doi.org/10.1124/dmd.30.5.608
  12. Diplock, A. T., Rice, C. A. and Burdon, R. H. (1994) Is there a significant role for lipid peroxidation in the causation of malignancy and for antioxidants in cancer prevention. Cancer. Res. 54, 1952-1956
  13. Dragon, Y. P., Xu, Y. D. and Pilot, H. C. (1998) Tumour promotion as a target for estrogen/antiestrogen effects in rat hepatocarcinogenesis. Prev. Med. 20, 15-26 https://doi.org/10.1016/0091-7435(91)90003-M
  14. Ellman, G. L. (1959) Tissue sulfahydryl groups. Arch. Biochem. Biophys. 82, 70-77 https://doi.org/10.1016/0003-9861(59)90090-6
  15. Emile, F. N., Dragan, Y. P., Colin, R. J., Jordan, V. C. and Pitot, H. C. (1995) Effects of tamoxifen administration on the expression of xenobiotic metabolizing enzymes in rat liver. Cancer Res. 55, 1780-1786
  16. Fu, T. and Liu, G. (1992) Protective effects of dimethyl-4,4' dimethoxy-5,6,5',6'-dimethylene dioxybiphenyl-2,2'-dicarboxylate on damages of isolated rat hepatocytes induced by carbon tetrachloride and D-galactosamine. Biomed. Environ. Sci. 5, 185-194
  17. Habig, W. H., Pabst, M. J. and Jakoby, W. B. (1974) Glutathione- S-transferases. The first enzymatic step in mercaptouric acid formation. J. Biol. Chem. 249, 7130-7139
  18. Han, Y. and Liehr, J. G. (1992) Induction of covalent DNA adducts in rodents by tamoxifen. Cancer Res. 52, 1360-1363
  19. Hard, G. C., Iatropoulos, M. J., Jordan, K., Kaltenberg, O. P., Imondi, A. R. and Williams, G. M. (1993) Major difference in the hepatocarcinogenecity and DNA adduct forming ability between toremifene and tamoxifen in female rats. Cancer Res. 53, 4534-4541
  20. Hellmann-Blumberg, U., Taras, T. L., Wurz, G. T. and DeGreorio, M. W. (2000) Genotoxic effects of the novel antiestrogenic FC- 1271a in comparison to tamoxifen and toremifene. Breast Cancer Res. Treat. 60, 63-70 https://doi.org/10.1023/A:1006311214152
  21. Hemminki, K., Widlak, P. and Hou, S. M. (1995) DNA adducts caused by tamoxifen and toremifene in human microsomal system and lymphocytes in vitro. Carcinogenesis 16, 1661- 1664 https://doi.org/10.1093/carcin/16.7.1661
  22. Hong, Y. H. (1986) Antibacterial effect of DDB; in Oriental Materia Medica: A Concise Guide, p. 65, Oriental Healing Arts Institute, Long Beach, USA
  23. Ip, S. P., Yiu, H. Y. and Ko, K. M. (2000) Differential effects of schisandrin B and dimethyl diphenyl bicarboxylate (DDB) on hepatic mitochondrial glutathione redox status in carbon tetrachloride intoxicated mice. Mol. Cell Biochem. 205, 111- 114 https://doi.org/10.1023/A:1007065917665
  24. Jordan, V. C. (2003) Tamoxifen: a most unlikely pioneering medicine. Natl. Rev. Drug. Discov. 2, 205-213 https://doi.org/10.1038/nrd1031
  25. Karki, A., Mantyla, E., Hirsimaki, Y., Karlsson, S., Toikkanen, S. and Hirsimaki, P. (2000) Comparison of the effects of tamoxifen and toremifene on rat hepatocarcinogenesis. Arch. Toxicol. 74, 249-256 https://doi.org/10.1007/s002040000116
  26. Kim, J., Baek, M., Lee, S., Kim, S., Dong, M., Kim, B. and Kim, D. (2001) Characterization of the Selectivity and Mechanism of Cytochrome P450 Inhibition by Dimethyl-4,4'-dimethoxy- 5,6,5',6'-dimethylenedioxybiphenyl-2,2'-dicarboxylate, Drug Metab. Dispos. 29, 1555-1560
  27. Kim, S. N., Kim, S. Y., Yim, S. Y., Lee, W. Y., Ham, K. S., Kim, S. K., Yoon, M. Y. and Kim, Y. C. (1999) Effect of dimethyl- 4,4'-dimethoxy-5,6,5',6'-dimethylene dioxybiphenyl-2,2'-dicarboxylate (DDB) on chemical induced liver injury. Biol. Pharm. Bull. 22, 93-95 https://doi.org/10.1248/bpb.22.93
  28. Kupfer, D., Mani, C., Lee, C. and Rifkind, A. (1994) Induction of tamoxifen-4-hydroxylation by 2,3,7,8-tetrachlorodibenzo-pdioxin (TCDD), beta-naphthoflavone (beta NF), and phenobarbital (PB) in avian liver: identification of P450 TCDDAA as catalyst of 4-hydroxylation induced by TCDD and beta NF. Cancer Res. 54, 3140-3144
  29. Letteron, P., Labbe, G., Degott, C., Berson, A., Fromenty, B., Delaforge, M., Larrey, D. and Pessayre, D. (1990) Mechanism for the protective effects of silymarin against carbon tetrachloride-induced lipid peroxidation and hepatotoxicity in mice. Evidence that silymarin acts both as an inhibitor of metabolic activation and as a chain-breaking antioxidant. Biochem. Pharmacol. 39, 2027-2034 https://doi.org/10.1016/0006-2952(90)90625-U
  30. Li, X. J., Zhao, B. L., Liu, G. T. and Xin, W. J. (1990) Scavenging effects on active oxygen radicals by schizandrins with different structures and configurations. Free Radic. Biol. Med. 9, 99-104 https://doi.org/10.1016/0891-5849(90)90111-U
  31. Li, X. Y. (1991) Bioactivity of neolignans from fructus Schizandrae. Mem. Inst. Oswaldo Cruz. 86, 31-37 https://doi.org/10.1590/S0074-02761991000600010
  32. Liu, G. T. (1989) Pharmacological actions and clinical use of fructus Schizandrae. Chin. Med. J. 102, 740-749
  33. Liu, C. S., Fang, S. D., Huang, M. F., Kao, Y. L. and Hsu, J. S. (1978) Studies on the active principles of Schisandra sphenanthera Rehd. et Wils. The structures of schisantherin A, B, C, D, E, and the related compounds. Sci. Sin. 21, 483-502
  34. Liu, Z., Shi, H. Y., Nawaz, Z. and Zhang, M. (2004) Tamoxifen induces the expression of maspin through estrogen receptor alpha. Cancer Lett. 209, 55-65 https://doi.org/10.1016/j.canlet.2003.11.018
  35. Lu, H. and Liu, G. T. (1991) Effect of dibenzo[a,c]cyclootene lignans isolated from fructus Schizandrae on lipid peroxidation and anti-oxidative enzyme activity. Chem. Biol. Interact. 78, 77-84 https://doi.org/10.1016/0009-2797(91)90104-F
  36. McCay, P. B., Lai, E. K., Poyer, J. L., Dubose, C. M. and Janzen, E. C. (1984) Oxygen and carbon centered free radical formation during carbon tetrachloride metabolism. Observation of lipid radicals in vivo and in vitro. J. Biol. Chem. 259, 2135- 2143
  37. Oge, A., Sezer, E. D., Ozgonul, M., Bayraktar, F. and Sozmen, E. Y. (2003) The effects of estrogen and raloxifene treatment on the antioxidant enzymes and nitrite-nitrate levels in brain cortex of ovarictomized rats. Neurosci. 338, 217-220
  38. Ohkawa, H., Ohishi, N. and Yagi, K. (1979) Assay for lipid peroxides in animal tissues by thiobarbituric reaction. Anal. Biochem. 95, 351-358 https://doi.org/10.1016/0003-2697(79)90738-3
  39. Pagano, G., deBiase, A., Deeva, I. B., Degan, P., Doronin, Y. K., Iaccarino, M., Oral, R. and Korkina, L. G. (2001) The role of oxidative stress in development and reproductive toxicity of tamoxifen. Life Sci. 68, 1735-1749 https://doi.org/10.1016/S0024-3205(01)00969-9
  40. Palomero, J., Galan, A. I., Munoz, M. E., Tunon, M. J., Gonzalez- Gallego, J. and Jimenez, R. (2001) Effects of aging on the susceptibility to the toxic effects of cyclosporine A in rats. Changes in liver glutathione and antioxidant enzymes. Free Rad. Biol. Med. 30, 836-845 https://doi.org/10.1016/S0891-5849(01)00471-3
  41. Panossian, A. G., Oganessian, A. S., Ambartsumian, M., Gabrielian, E. S., Wagner, H. and Wikman, G. (1999) Effects of heavy physical exercise and adaptogens on nitric oxide content in human saliva. Phytomedicine 9, 17-26
  42. Qi-Change, X., Lin, L., Degao, W. and Gen-Jun, X. (1987) Microassay of glutathione peroxidase by reduced phase HPLC. Chromatogram 9, 11-14
  43. Rosen, G. M., Britigan, B. E., Halpern, H. J. and Pou, S. (1999) Spin trapping free radicals in biological systems; in Free Radicals, Biology and Detection by Spin Trapping, p. 394, New York: Oxford Press, Oxford, United Kingdom
  44. Saarto, T., Blomqvist, C., Ehnholm, C., Taskinen, M. R. and Elomaa, I. (1996) Antiatherogenic effects of adjuvant antiestrogens: a randomized trial comparing the effects of tamoxifen on plasma lipid levels in postmenopausal women. J. Clin. Oncol. 14, 429-433
  45. Simeone, A. M., Ekmikciolu, S., Grimm, E. A. and Tari, A. M. (2002) A novel mechanism by which retinamide inhibits breast cancer growth: the production of nitric oxide. Mol. Cancer Ther. 1, 1366
  46. Sinclair, S., (1998) Chinese herbs: a clinical review of astragalus, ligusticum, and schizandrae. Altern. Med. Rev. 3, 338-344
  47. Sridar, C., Kent, M., Notley, L., Gillam, E. and Hollenberg, P. (2002) Effect of Tamoxifen on the Enzymatic Activity of Human Cytochrome CYP2B6. Pharmacol. Exp. Therapeutics 301, 945-952 https://doi.org/10.1124/jpet.301.3.945
  48. Stanley, L. A., Carthew, P., Davies, R., Higginson, F., Martin, E. and Stayles, J. A. (2001) Delayed effects of tamoxifen in hepatocarcinogenesis. Cancer Lett. 171, 27 https://doi.org/10.1016/S0304-3835(01)00564-X
  49. Stefano, G. B., Cadet, P., Mantione, K., Cho, J. J., Jones, D. and Zhu, W. (2003) Estrogen signaling at the cell surface coupled to nitric oxide release in Mytilus edulis nervous system. Endocrinology 144, 1234-1240 https://doi.org/10.1210/en.2002-220967
  50. Williams, G. M., Iatropoulos, M. J., Djordjevic, M. V. and Kaltenberg, O. P. (1993). The triphenylethylene drug tamoxifen is a strong liver carcinogen in the rat. Carcinogenesis 14, 315- 317 https://doi.org/10.1093/carcin/14.2.315
  51. White, B. A., Erickson, M. M. and Stevens, S. C. (1970) Determination of sGoT and sGPT enzymes; in Chemistry for Medical Technologists, pp. 293-296, Mosby, Saint Louis, USA
  52. Yu, F. L. and Bender, W. (2002) A proposed mechanism of tamoxifen in breast cancer prevention. Cancer Detect. Prev. 26, 370-375 https://doi.org/10.1016/S0361-090X(02)00124-1
  53. Yu, H. Q., Yang, X. U., Zang, Y. X. and Shi, J. Z. (1987) Biphenyl-dimethyl dicarboxylate in treating and preventing hepatitis due to drug poisoning. Chinese Med. J. Peking. 100, 122-123
  54. Zohny, S., Kandil, E., Moselhy, S. and Mohamed, E. (2001) Antioxidant properties of biphenyl dimethyl dicarboxylate, silymarin and garlic homogenates in carbon tetrachlorideinduced rat liver injury. Egy. J. Biochem. Mol. Biol. 20, 47-62

Cited by

  1. Influence of gender on tamoxifen-induced biochemical changes in serum of rats vol.301, pp.1-2, 2007, https://doi.org/10.1007/s11010-006-9405-2
  2. Effect of biphenyl dimethyl dicarboxylate and fluoxetine on performance of normally-fed and protein malnourished psychologically stressed mice in elevated plus maze vol.52, pp.1, 2014, https://doi.org/10.1016/j.bfopcu.2014.04.004
  3. Liquiritigenin, an aglycone of liquiritin in Glycyrrhizae radix, prevents acute liver injuries in rats induced by acetaminophen with or without buthionine sulfoximine vol.161, pp.2, 2006, https://doi.org/10.1016/j.cbi.2006.03.008
  4. A fungal taxol from Botryodiplodia theobromae Pat., attenuates 7, 12 dimethyl benz(a)anthracene (DMBA)-induced biochemical changes during mammary gland carcinogenesis vol.1, pp.2, 2011, https://doi.org/10.1016/j.bionut.2011.04.002
  5. Study on four polymorphs of bifendate based on X-ray crystallography vol.6, pp.3, 2016, https://doi.org/10.1016/j.apsb.2016.03.006
  6. The metabolism and excretion of 2-methylaminoethoxycarbonyl-4,4′-dimethoxy-5,6,5′,6′-dimethylenedioxybiphenyl-2′-carboxylic acid (DDB-S) in rats and human vol.20, pp.13, 2006, https://doi.org/10.1002/rcm.2549
  7. Effect of Coenzyme Q10, Riboflavin and Niacin on Tamoxifen treated postmenopausal breast cancer women with special reference to blood chemistry profiles vol.114, pp.2, 2009, https://doi.org/10.1007/s10549-008-0012-7
  8. Augmented antioxidant status in Tamoxifen treated postmenopausal women with breast cancer on co-administration with Coenzyme Q10, Niacin and Riboflavin vol.61, pp.6, 2008, https://doi.org/10.1007/s00280-007-0547-z
  9. Curcumin protects rats against acetaminophen-induced hepatorenal damages and shows synergistic activity with N-acetyl cysteine vol.628, pp.1-3, 2010, https://doi.org/10.1016/j.ejphar.2009.11.027
  10. Therapeutic Effect of Silybum marianum Plant Extract on Tamoxifen-Induced Fatty Liver in Rats vol.3, pp.1, 2015, https://doi.org/10.17795/ajmb-27160
  11. Tamoxifen for the prevention of postoperative intra-abdominal adhesions vol.47, pp.2, 2015, https://doi.org/10.1007/s10353-015-0306-z
  12. Spectroscopic study on the interaction of catalase with bifendate and analogs vol.102, 2013, https://doi.org/10.1016/j.saa.2012.10.039
  13. A Herbal Formula, CGXII, Exerts Antihepatofibrotic Effect in Dimethylnitrosamine-Induced SD Rat Model vol.2016, 2016, https://doi.org/10.1155/2016/5093718
  14. Hepatoprotective effect ofAmomum xanthoidesagainst dimethylnitrosamine-induced sub-chronic liver injury in a rat model vol.51, pp.7, 2013, https://doi.org/10.3109/13880209.2013.770040
  15. An herbal fruit, Amomum xanthoides, ameliorates thioacetamide-induced hepatic fibrosis in rat via antioxidative system vol.135, pp.2, 2011, https://doi.org/10.1016/j.jep.2011.03.026
  16. Effect of bifendate on the pharmacokinetics of cyclosporine in relation to the CYP3A4*18B genotype in healthy subjects vol.30, pp.4, 2009, https://doi.org/10.1038/aps.2009.27
  17. Therapeutic effect of propolis and paclitaxel on hepatic phase I and II enzymes and marker enzymes in dimethylbenz(a)anthracene-induced breast cancer in female rats vol.143, pp.3, 2006, https://doi.org/10.1016/j.cbpc.2006.03.009
  18. Attenuation of tamoxifen-induced hepatotoxicity by taurine in mice vol.370, pp.1-2, 2006, https://doi.org/10.1016/j.cca.2006.02.006
  19. Hepatoprotective Activity of Dandelion (Taraxacum officinale) Water Extract against D-Galactosamine-Induced Hepatitis in Rats vol.37, pp.2, 2008, https://doi.org/10.3746/jkfn.2008.37.2.177
  20. Catechin prevents tamoxifen-induced oxidative stress and biochemical perturbations in mice vol.225, pp.2-3, 2006, https://doi.org/10.1016/j.tox.2006.05.009
  21. Therapeutic potential of Dendrophthoe falcata (L.f) Ettingsh on 7,12-dimethylbenz(a)anthracene-induced mammary tumorigenesis in female rats: effect on antioxidant system, lipid peroxidation, and hepatic marker enzymes vol.20, pp.4, 2011, https://doi.org/10.1007/s00580-010-1008-3
  22. Taurine Prevents Tamoxifen-Induced Mitochondrial Oxidative Damage in Mice vol.102, pp.4, 2008, https://doi.org/10.1111/j.1742-7843.2008.00208.x
  23. Antifibrotic effects of ZK14, a novel nitric oxide-donating biphenyldicarboxylate derivative, on rat HSC-T6 cells and CCl4-induced hepatic fibrosis vol.31, pp.1, 2010, https://doi.org/10.1038/aps.2009.170
  24. Therapeutic effect of dimethyl dimethoxy biphenyl dicarboxylate on collagen-induced arthritis in rats vol.21, pp.11, 2015, https://doi.org/10.1007/s11655-014-1746-1
  25. Spectroscopic study on the interaction of Trypsin with Bicyclol and analogs vol.118, 2014, https://doi.org/10.1016/j.saa.2013.09.027
  26. The Effect Of The Oral Iron Chelator Deferiprone On The Liver Damage Induced By Tamoxifen In Female Rats vol.35, pp.3, 2011, https://doi.org/10.3109/03630269.2011.560780
  27. Potential anti-genotoxic effect of sodium butyrate to modulate induction of DNA damage by tamoxifen citrate in rat bone marrow cells vol.69, pp.1, 2017, https://doi.org/10.1007/s10616-016-0039-2
  28. Evaluation of nephroprotective, diuretic, and antioxidant activities ofplectranthus amboinicuson acetaminophen-induced nephrotoxic rats vol.20, pp.4, 2010, https://doi.org/10.3109/15376511003736787